Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy

Vaccine

Volumn 27, Issue 36, 2009, Pages 4876-4878

  Ojaimi, Samar ^a   Buttery, Jim P ^a   Korman, Tony M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Gardasil; Human Papillomavirus vaccine; Lipoatrophy

Indexed keywords

CORTICOSTEROID; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INSULIN; PENICILLIN DERIVATIVE; RECOMBINANT VACCINE; WART VIRUS VACCINE;

ADULT; ARTICLE; AUSTRALIA; CASE REPORT; DRUG EFFECT; FEMALE; FEVER; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; LIPOATROPHY; PRIORITY JOURNAL; VACCINATION;

ADULT; FEMALE; HUMANS; LIPODYSTROPHY; PAPILLOMAVIRUS VACCINES; VACCINES, SYNTHETIC; YOUNG ADULT;

EID: 67650504077     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.026     Document Type: Article

References (24)

1. Ahmed I. Post-injection involutional lipoatrphy: ultrastructural evidence for an activated macrophage phenotype and macrophage related involution of adipocytes. Am J Dermatopathol 28 (2006) 334-337
2. Kalouche H., and Whitfeld M.J. Leg crossers' dimple: a form of localised lipoatrophy. Australs J Dermatol 47 (2006) 253-257
3. Kuperman-Beade M., and Laude T.A. Partial lipoatrophy in a Child. Pediat Dermatol 17 4 (2000) 302-303
4. Sardana K., Garg V.K., Bhushan P., Relhan V., and Sharma S. DPT vaccine-induced lipoatrophy: an observational study. Int J Dermatol 46 (2007) 1050-1054
5. Zimmerman R.K. HPV vaccine and its recommendations. J Fam Pract 56 2 (2007) S1-S5
6. Huang C. Human papillomavirus and vaccination. Mayo Clin Proc 83 6 (2008) 701-707
7. Asif M., Siddiqui A., and Perry C.M. Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil). Drugs 66 9 (2006) 1263-1271
8. Barr E., and Sings H. Prophylactic HPV vaccines: new interventions for cancer control. Vaccine 26 (2008) 6244-6257
9. Schiffman M., Castle P.E., Jeronimo J., Rodriques A.C., and Wacholder S. Human papillomavirus and cervical cancer. Lancet 370 (2007) 890-907
10. National Centre for immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) for the Australian Technical Advisory Group on Immunisation (ATAGI). Systematic review of the safety, immunogenecity and efficacy of human papillomavirus vaccines. March; 2007.
11. Moore D. Cervical cancer. Obstet Gynecol 107 (2006) 1152-1161
12. Merck Sharp & Dohme. Gardasil product information (2008), Merck Sharp & Dohme
13. Australian Governement. The Australian immunisation handbook. 9th ed. (2008), Australian Governement. http://www.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook-home
14. Koulova A., Tsui J., Irwin K., Van Damme P., Biellik R., and Aguado M.T. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008. Vaccine 26 (2008) 6529-6541
15. Rambout L., Hopkins L., Hutton B., and Ferguson D. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ 177 5 (2007) 469-479
16. Barr E., and Tamms G. Quadrivalent human papillomavirus vaccine. CID 45 5 (2007) 609-617
17. Buttery J., Madin S., Crawford N., Elia S., La Vincente S., Hanieh S., et al. Mass psychogenic response to human papillomavirus vaccination. MJA 189 5 (2008) 261-262
18. US Food and Drug Administration, Centre for Biologics Evaluation and Research. Information from CDC and FDA on the safety of Gardasil vaccine. [Accessed July 14th 2008] http://www.fda.gov/cber/safety/gardasil071408.htm.
19. Brotherton J.M.L., Gold M.S., Kemp A.S., McIntyre P.B., Burgess M.A., and Campbell-lloyd S. Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ 179 6 (2008) 525-533
20. Kang L.W., Crawford N., Tang M.L.K., Buttery J., Royle J., Gold M., et al. Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study. BMJ 337 (2008) a2642
21. Vaccine Adverse Event Reporting System. [Accessed May 9th 2009] http://vaers.hhs.gov/.
22. Dahl P.R., Zalla M.J., and Winkelmann K. Localized involutional lipoatrophy: a clinicopathologic study of 16 patients. J Am Acad Dermatol 35 (1996) 523-528
23. Abbas O., Salman S., Ghani A., Chedraoui A., and Ghosn S. Localized involutional lipoatrophy with epidermal and dermal changes. J Am Acad Dermatol 58 (2008) 490-493
24. Diggle L., Deeks J.J., and Pollard A.J. Effect of needle size on immunogenicity and reactognicity of vaccines in infants: randomised controlled trial. BMJ 333 (2006) 571-574